Scientists from the Institute of Medical Biology are preparing for final phase trials of their Covid-19 vaccine candidate. Photo: Getty Images Scientists from the Institute of Medical Biology are preparing for final phase trials of their Covid-19 vaccine candidate. Photo: Getty Images
Scientists from the Institute of Medical Biology are preparing for final phase trials of their Covid-19 vaccine candidate. Photo: Getty Images

Coronavirus: risk of ADE low with new Chinese vaccine candidate, researchers say

  • Antibody-dependent enhancement (ADE) is a side-effect of inoculation that can make a virus more harmful
  • Team from Institute of Medical Biology say they cannot conclude their product will not cause ADE, but ‘likelihood as a result of inoculation with this vaccine is small’

Topic |   Coronavirus China
Scientists from the Institute of Medical Biology are preparing for final phase trials of their Covid-19 vaccine candidate. Photo: Getty Images Scientists from the Institute of Medical Biology are preparing for final phase trials of their Covid-19 vaccine candidate. Photo: Getty Images
Scientists from the Institute of Medical Biology are preparing for final phase trials of their Covid-19 vaccine candidate. Photo: Getty Images
READ FULL ARTICLE